Discover signature dysregulations in the molecular mechanisms involved in the cell, tissue functions and phenotypes associated with your disease of interest. Assess their suitability as biomarkers on multiple criteria. Available as platform subscription or consulting service.
BIOMARKER DISCOVERY EXAMPLE
Discover signature dysregulations in the molecular interactions driving disease pathology
Leverage our millions of gene annotations and combine these with your personal data. Discover and evaluate how molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology. Identify signature dysregulations resulting from these pathologies.
Specific, Predictive and Non-Invasive Biomarkers
From the list of potential signature dysregulations, evaluate most promising biomarkers by ranking, filtering and scoring simultaneously on multiple key aspects such as differential expression and bioavailability.
Latest Biomarker Discovery news
Researchers use 1.58 million protein relations from Euretos AI Platform to predict drug efficacy for diseases with 78% accuracyTuesday 02 October 2018
In a recent publication in the Journal of Biomedical Semantics, researchers from the Erasmus University Medical Center (EMC) in Rotterdam have presented a machine learning (ML) model that predicts with 78% accuracy whether a drug is efficacious for ...
Euretos Analytics confirms novel biomarker for chronic kidney diseaseThursday 10 December 2015
A recent article published in Science Translational Medicine has shown that EGF protein levels in urine is a reliable biomarker for chronic kidney disease (CKD), one of the world's major diseases. The earlier this disease is diagnosed the bett ...